The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1613
December 14, 2020
View Complete Issue         Table of Contents 2019 
Drugs for Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Asthma
December 14, 2020 (Issue: 1613)
The goal of asthma treatment is to control symptoms, prevent exacerbations, and maintain normal lung function. Management of acute exacerbations of asthma in the emergency department is not discussed here.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Asthma
Article code: 1613a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.